Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based anti-tumor immunity enhancement therapy: MiRNA-128-2 promotes anti-tumor immunity via down regulation of its target gene, 27/February/2015, 23.02, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-128-2, by inducing the expression of its target gene, it may promote anti-tumor immunity. Thereby, it may inhibit tumor progression. Thus, pharmacological formulations encompassing “MiRNA-128-2 or its activators” may be used to inhibit tumor progression.
Amount: $ 500*
Undisclosed information: How MiRNA-128-2 promotes anti-tumor immunity
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org